These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35177154)

  • 1. Laryngeal dysplasia: a 10-year review of rates of progression to invasive carcinoma and treatment-specific outcomes in a regional ENT department in Northern Ireland.
    Donaldson G; McCadden L; Napier S; Tan TJ
    J Laryngol Otol; 2022 Jun; 136(6):547-553. PubMed ID: 35177154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk and interval to malignancy of patients with laryngeal dysplasia; a systematic review of case series and meta-analysis.
    Weller MD; Nankivell PC; McConkey C; Paleri V; Mehanna HM
    Clin Otolaryngol; 2010 Oct; 35(5):364-72. PubMed ID: 21108746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The problems and question marks in precancerous lesions of the larynx].
    Wierzbicka M; Pastusiak T; Kaczmarek J; Szyfter W
    Otolaryngol Pol; 2007; 61(1):47-51. PubMed ID: 17605418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laryngeal dysplasia, demographics, and treatment: a single-institution, 20-year review.
    Karatayli-Ozgursoy S; Pacheco-Lopez P; Hillel AT; Best SR; Bishop JA; Akst LM
    JAMA Otolaryngol Head Neck Surg; 2015 Apr; 141(4):313-8. PubMed ID: 25654369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and malignant transformation of glottic precursor lesions in Denmark.
    Sannino NJB; Mehlum CS; Grøntved ÅM; Kjaergaard T; Kiss K; Godballe C; Tvedskov JF
    Acta Oncol; 2020 May; 59(5):596-602. PubMed ID: 32098535
    [No Abstract]   [Full Text] [Related]  

  • 6. A decade of laryngeal dysplasia in Paisley, Scotland.
    Montgomery J; White A
    Eur Arch Otorhinolaryngol; 2012 Mar; 269(3):947-51. PubMed ID: 21739097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysplastic Changes in Patients with Recurrent Laryngeal Leukoplakia: Importance of Long-Term Follow-Up.
    Jabarin B; Pitaro J; Marom T; Muallem-Kalmovich L
    Isr Med Assoc J; 2018 Oct; 20(10):623-626. PubMed ID: 30324779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laryngeal dysplasia: a long-term follow-up study.
    Theodosiou MG; Yiotakis J; Dikoglou C; Lazaris AC; Athanasiadis-Sismanis A; Xenellis J
    J BUON; 2013; 18(3):683-8. PubMed ID: 24065483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term follow-up study of laryngeal precancer.
    Plch J; Pár I; Navrátilová I; Bláhová M; Zavadil M
    Auris Nasus Larynx; 1998 Dec; 25(4):407-12. PubMed ID: 9853665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laryngeal dysplasia: epidemiology and treatment outcome.
    Blackwell KE; Calcaterra TC; Fu YS
    Ann Otol Rhinol Laryngol; 1995 Aug; 104(8):596-602. PubMed ID: 7639467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grade of dysplasia and malignant transformation in adults with premalignant laryngeal lesions.
    van Hulst AM; Kroon W; van der Linden ES; Nagtzaam L; Ottenhof SR; Wegner I; Gunning AC; Grolman W; Braunius W
    Head Neck; 2016 Apr; 38 Suppl 1():E2284-90. PubMed ID: 26268427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analyses of 263 patients with laryngeal leukoplakia].
    Niu YY; Wang J; Huo H; Jin XF; Li WY; Gao ZQ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Aug; 53(8):575-580. PubMed ID: 30121994
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential biomarkers in predicting progression of epithelial hyperplastic lesions of the larynx.
    Gallo O; Franchi A; Chiarelli I; Porfirio B; Grande A; Simonetti L; Bocciolini C; Fini-Storchi O
    Acta Otolaryngol Suppl; 1997; 527():30-8. PubMed ID: 9197477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laryngeal dysplasia: Oncological outcomes in a large cohort of patients treated in a tertiary comprehensive cancer centre.
    Chu F; De Santi S; Tagliabue M; De Benedetto L; Zorzi S; Pietrobon G; Herman I; Maffini F; Chiocca S; Corso F; Gandini S; Ansarin M
    Am J Otolaryngol; 2021; 42(2):102861. PubMed ID: 33445041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic variability of laryngeal premalignant lesions: histological evaluation and carcinoma transformation.
    Hu Y; Liu H
    Otolaryngol Head Neck Surg; 2014 Mar; 150(3):401-6. PubMed ID: 24367051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant Transformation of Dysplastic Vocal Fold Lesions: A Systematic Review and Meta-Analysis.
    Horton G; Philteos J; Lin RJ
    JAMA Otolaryngol Head Neck Surg; 2024 Jul; 150(7):556-563. PubMed ID: 38753339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
    Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
    J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords--a follow-up study.
    Hellquist H; Lundgren J; Olofsson J
    Clin Otolaryngol Allied Sci; 1982 Feb; 7(1):11-27. PubMed ID: 7037233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.
    Bhat S; Coleman HG; Yousef F; Johnston BT; McManus DT; Gavin AT; Murray LJ
    J Natl Cancer Inst; 2011 Jul; 103(13):1049-57. PubMed ID: 21680910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3p21, 5q21, 9p21 and 17p13 allelic deletions accumulate in the dysplastic spectrum of laryngeal carcinogenesis and precede malignant transformation.
    Sanz-Ortega J; Valor C; Saez MC; Ortega L; Sierra E; Poch J; Hernández S; Sanz-Esponera J
    Histol Histopathol; 2003 Oct; 18(4):1053-7. PubMed ID: 12973674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.